Stanford Medicine
by Stanford Medicine
· Based in United States →
— A leader in the biomedical revolution, Stanford Medicine is ushering in the era of Precision Health. This high-tech, high-touch approach to patient care seeks to not only treat disease but to predict, prevent, and cure it—precisely.
Documentation ProvidedRegulatory Status Disclosed
Overview
Stanford Medicine’s Nuclei.io platform offers a suite of AI tools designed to integrate into clinical workflows. The platform is intended for various medical specialties and care settings, aiming to enhance efficiency and provide data-driven insights.
- What it does: Nuclei.io provides AI-powered solutions for tasks such as medical image analysis, predictive analytics, and clinical decision support. It processes diverse healthcare data to generate actionable insights for clinicians.
- Who it is for: The tools are applicable across multiple specialties, including but not limited to radiology, cardiology, and oncology, and can be utilized in both inpatient and outpatient care settings.
- How it fits a clinical or practice workflow: Nuclei.io tools are designed to integrate with existing electronic health record (EHR) systems and picture archiving and communication systems (PACS). For example, an AI model might analyze a medical image and flag potential areas of concern for a radiologist to review, or provide a risk score for a patient based on their clinical data, assisting physicians in their diagnostic and treatment planning processes.
- Notable capabilities: The platform emphasizes its ability to leverage large datasets for model training, offering customizable AI solutions tailored to specific clinical needs. It focuses on providing tools that can adapt to evolving medical knowledge and practice patterns.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Open-source platform
- Secure data handling environment
- Tools for model training and validation
- Integration mechanisms for healthcare systems
- Support for various medical AI applications
- Emphasis on reproducibility and collaboration
Use Cases
- Developing new medical AI models
- Testing and validating AI algorithms
- Integrating AI solutions into clinical workflows
- Facilitating collaborative AI research
- Educating on medical AI development
What Physicians Need to Know
Evidence Base
Nuclei.io is an AI-based digital pathology framework developed at Stanford Medicine. It is designed to improve workflow and diagnosis in cancer and other diseases. The tool is described in a Nature Biomedical Engineering paper. Stanford Medicine's Clinical Decision Support Hub also offers tools like BiliRecs, which follows AAP 2022 guidelines for indirect hyperbilirubinemia in newborns, and an interactive guide for blood transfusions offering evidence-based recommendations.
Clinical Validation Studies
In initial trials at Stanford Medicine, doctors using Nuclei.io to diagnose endometritis or metastatic colon cancer were 62% faster and 72% more accurate than without the program. The framework's effectiveness was validated via two crossover user studies, demonstrating considerable diagnostic performance improvements in identifying plasma cells in endometrial biopsies and detecting colorectal cancer metastasis in lymph nodes. Research also indicates that physicians supported by AI-powered chatbots performed as well as the chatbots alone in making nuanced clinical decisions.
Alert Fatigue Management
While not specifically detailed for Nuclei.io, Stanford Medicine acknowledges the broader challenge of alert fatigue in healthcare. General principles for managing alert fatigue in CDS systems include smarter alert prioritization and workflow-aware CDS design. The goal is to ensure AI supports, rather than replaces, clinical judgment, and that workflows are well-designed to avoid undermining even advanced tools.
Differential Diagnosis Support
Nuclei.io assists pathologists in identifying abnormal cells in blood samples or biopsies, guiding them to areas that need a closer look rather than making diagnoses independently. This personalized assistance helps in spotting cells linked to diseases like cancer or endometritis. Stanford Medicine also has a Clinical Informatics Consult Service that leverages electronic health records to provide insights for challenging diagnoses.
Guideline Update Frequency
Stanford Medicine's Clinical Decision Support Hub emphasizes a rapid, iterative development cycle and clinician-driven innovations to quickly evaluate and refine tools based on user feedback. For tools like BiliRecs, it follows current guidelines such as AAP 2022. The framework for auditable AI decision support also highlights the importance of knowledge-base governance and updating.
Clinical Workflow Integration
Nuclei.io is designed to improve workflow by learning from pathologists and adapting to individual workflows, offering personalized assistance. It allows pathologists to share their models with colleagues, facilitating collaboration. Stanford Medicine's CDS tools are generally designed to be EMR agnostic, allowing for seamless integration into any Electronic Medical Record system. They are committed to engaging clinicians in the development process to effectively address real-world challenges and ensure efficient integration with existing EHR systems and enhanced clinical workflows.
Decision Audit Trail
A conceptual framework for auditable and source-verified AI-based clinical decision support, grounded in principles from evidence-based medicine, data provenance, and trustworthy AI, has been proposed. This framework includes a tamper-evident audit logging mechanism that records system inputs, retrieved evidence, and inference steps for retrospective review.
Physician Tip
Nuclei.io is designed to augment, not replace, a pathologist's expertise. Leverage its ability to quickly highlight suspicious areas and customize its learning to your specific workflow for increased efficiency and accuracy. Collaborate with colleagues by sharing models to build on collective expertise. Remember that the AI is a tool to support your judgment, not to make the final diagnosis.
Stanford Medicine's clinical decision support tools, including those from the Clinical Decision Support Hub, are designed to be EMR agnostic for seamless integration into various Electronic Medical Record systems. Nuclei.io's open-source nature also allows for adoption by other institutions. The development process emphasizes clinician engagement and rapid, iterative cycles for efficient integration with existing EHR systems.
Details
| Category | Clinical Decision Support & Reference, Developer Tools & APIs, Medical Education & Training |
| Pricing |
Unknown
|
| Mobile App | Yes |
| Data Export | Unknown |
| Training | Unknown |
| Compliance | |
| BAA Available | Yes AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status |
Not applicable AI-estimated Stanford Medicine has developed various treatments and technologies that have received FDA designations or approvals. For example, a promising treatment for pediatric brain and spinal cord cancers received a Regenerative Medicine Advanced Therapy (RMAT) designation to expedite the FDA approval process. Additionally, a Stanford Medicine-developed drug for a rare cardiovascular disease (transthyretin amyloid cardiomyopathy) has been approved by the FDA. A Stanford Medicine-led trial also resulted in FDA approval for a drug treating a rare blood cancer. More recently, a Stanford startup, UpDoc, received 510(k) clearance for an AI agent for insulin management in patients with Type 2 diabetes. It's important to note that while Stanford Medicine develops and researches FDA-approved treatments and technologies, compounded drugs offered by some pharmacies, even if related to GLP-1s, do not have the same FDA approval as brand-name drugs and raise safety concerns. |
| Integrations | |
| EHR | Not specified |
| Specialties | Internal Medicine, Pathology, Radiology |
Social Proof
| Customers | unknown |
| Notable | Stanford Medicine |
Support & Reliability
| Training Provided | Unknown |
What the Web Says
Nuclei.io is an AI-powered digital pathology framework developed at Stanford Medicine that aims to enhance the speed and accuracy of disease diagnoses by assisting pathologists in identifying abnormal cells. The tool is designed to be customizable, learning from individual pathologists' feedback, and facilitates collaboration among medical professionals. Initial trials have shown significant improvements in diagnostic efficiency and accuracy, particularly in detecting conditions like endometritis and metastatic colon cancer.
Overall: PositiveStrengths
- Increases diagnostic speed by up to 62%.
- Improves diagnostic accuracy by up to 72%.
- Customizable and adapts to individual pathologists' workflows.
- Facilitates collaboration and knowledge sharing among pathologists.
- Emphasizes nuclear features for detailed single-cell analysis.
- Reduces the need for additional staining in some cases.
Limitations
- AI integration in medical practices faces challenges due to a lack of standardized regulations, concerns about device reliability, inherent biases, and patient privacy.
- Requires sufficient and continuously updated data for training due to the vast number of disease classifications.
- Currently in the process of meeting compatibility and security benchmarks for broader deployment outside of research settings.
- No direct patient interaction.
Based on reviews from: Stanford Medicine News Center, MarkTechPost, PubMed, Stanford Report, Reddit, MindStudio
Last updated: 2026-07-27
Ratings & Reviews
Rate Stanford Medicine
Press & Coverage
ScienceDaily
AI helps Stanford scientists discover u201cnatural Ozempicu201d without the usual side effects
Stanford Medicine researchers, using AI, have discovered a naturally occurring molecule that may suppress appetite and reduce body weight similar to Ozempic, but without common side effects like nausea and constipation. The molecule, BRP, targets a more specific brain region involved in hunger and metabolism.
2026-07
Stanford Medicine News Center
Ribosomes' role in cell fate
Researchers at Stanford Medicine developed a tool called the Ribo-Tweezer to pluck individual components out of a mature ribosome, finding a surprising role for a protein called RACK-1.
2026-07
Stanford Medicine News Center
Agentic AI and scientific discovery
Stanford Medicine scientists are venturing into a new area of collaboration that relies on agentic AI, co-scientists that can act independently and help humans ideate, hypothesize and speed up scientific exploration.
2026-07
Stanford Medicine News Center
Compounded GLP-1s: Why doctors worry and the FDA is cracking down
Regulatory agencies have been increasing their oversight of compounded GLP-1s, with the FDA proposing to permanently exclude semaglutide, tirzepatide, and liraglutide from the u201c503B Bulks Listu201d due to concerns about dosing errors and fraudulent labeling.
2026-07
Stanford Medicine News Center
Breakdown of immune cells' interaction is key driver in aging, study finds
A Stanford Medicine study found that the interaction between two immune cell types plays a major role in aging, and blocking a hormone's influence on one of these cell types halted age-associated decline in multiple organs in mice.
2026-07
Stanford Medicine Children's Health
Brains of teens with autism 'tune in' less to unfamiliar voices, Stanford Medicine-led study finds
A Stanford Medicine-led study found that the brains of teenagers with autism show less engagement with unfamiliar voices.
2026-07
Clinical Excellence Research Center - Stanford Medicine
Addressing Medical Affordability Without Compromising Care
This Health Affairs article discusses how the US spends a significant portion of healthcare costs on administration, particularly billing, and suggests that standardizing and digitizing billing could lead to savings.
2026-07
Stanford Medicine News Center
Stanford Study Exposes Major Flaw in AI Mental Health Safety Testing
A Stanford study revealed a significant flaw in the safety testing of AI chatbots for mental health, noting that human experts often disagree on what constitutes a 'safe' response.
2026-07
Videos
Product demos, reviews, and walkthroughs for Stanford Medicine.
Loading videos...
Frequently Asked Questions
Stanford Medicine's CDS system is designed for seamless integration with major EHR platforms, often leveraging SMART on FHIR standards to embed alerts and recommendations directly within the physician's existing workflow. This approach aims to reduce 'alert fatigue' and ensure that critical information is presented at the point of care without requiring physicians to navigate to separate applications.
Stanford Medicine's CDS tools are developed based on the latest evidence-based guidelines and undergo rigorous internal validation. Studies and publications from Stanford often highlight improvements in patient safety, adherence to best practices, and reductions in diagnostic errors as a result of their CDS implementation.
Physicians using Stanford Medicine's CDS are expected to adhere to relevant institutional policies and professional guidelines regarding clinical decision support. The system itself is designed with an understanding of regulatory frameworks such as HIPAA and aims to support compliance with quality reporting initiatives.
While Stanford Medicine primarily utilizes and develops its own robust CDS solutions, they are often involved in research and evaluation of various health IT tools. Information on specific alternative recommendations would typically be found in their research publications or through direct consultation with their health informatics department.
The pricing structure for implementing and maintaining Stanford Medicine's CDS for external entities can vary significantly based on the scope of integration, customization needs, and ongoing support. Specific cost details would require direct consultation with Stanford Medicine's technology transfer or partnership offices.
Potential limitations of any CDS can include alert fatigue, the need for continuous updates to reflect new medical knowledge, and the challenge of integrating with highly diverse EHR systems. Stanford Medicine addresses these by continuously refining their algorithms, incorporating user feedback, and focusing on intelligent, context-aware alerting.
Stanford Medicine's CDS knowledge bases are updated regularly to reflect the latest medical research, clinical guidelines, and drug information. The process typically involves a multidisciplinary team of experts who review new evidence and integrate it into the system through a structured and validated methodology.
Suggest an Edit →
| Last Verified: 2026-07-27 | First Added: 2026-07-26